Horse chestnut

DB13195InvestigationalProtein Based Therapies

Horse chestnut is a plant extract indicated in the treatment of venous insufficiency and other disorders caused by poor circulation. Horse chestnut is a flowering plant commonly referred to as Aesculus hippocastanum.

First approval: Canada, 1948
Also known as: Aesculus hippocastanum · Hippocastani semen

Resolves to

Compound

UNII2331W47PSX

Clinical / RWD

RxNorm317825ATCC05CX03

What you can answer from here — as of November 18, 2025

7Clinical trialsPhase, status and sponsor resolved per trial

11Structured indicationsCondition, population, route and combination as fields, not prose

8ContraindicationsEach with its own population and attribute set

11Marketed productsAcross 5 countries and 7 labellers

1ATC codeIncluding every combination product, plus 15 drug categories

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Horse chestnut, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account